Taylor Ramsey
Family · Hickory, NCNPI 1164190476
Payments from drug & device makers
Across 215 payments — averaging $24.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$981
- Bayer$436
- AstraZeneca$380
- Exact Sciences$267
- Lilly USA, LLC$237
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,223100%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $1,305 |
| Novo Nordisk | 26 | $981 |
| Bayer | 27 | $436 |
| AstraZeneca | 14 | $380 |
| Exact Sciences | 6 | $267 |
| Lilly USA, LLC | 16 | $237 |
| GSK | 8 | $217 |
| Boehringer Ingelheim | 7 | $206 |
| Dexcom, Inc. | 2 | $143 |
| Medtronic | 2 | $138 |
| Pfizer | 6 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $96 |
| Otsuka America Pharmaceutical, Inc. | 5 | $84 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $82 |
| Idorsia Pharmaceuticals US Inc | 1 | $70 |
| Abbott | 5 | $66 |
| Astellas Pharma US Inc | 4 | $60 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Amgen | 3 | $47 |
| Johnson & Johnson | 2 | $41 |
| Currax Pharmaceuticals LLC | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Neos Therapeutics, LP | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $16 |
| Corcept Therapeutics | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Shield Therapeutics Inc | 1 | $13 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$349
- UBRELVY$249
- Saxenda$237
- DEXCOM G7 GSS (161)$125
- Kerendia$124
- TRELEGY ELLIPTA$116
- JARDIANCE$114
- RYBELSUS$113
- Cologuard Collection Kit$109
How this compares
$5,248 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 49 | $49,801 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $28,382 |
| JardianceEmpagliflozin | 27 | $27,634 |
| OzempicSemaglutide | 14 | $21,121 |
| RybelsusSemaglutide | 12 | $11,055 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 17 | $3,693 |
| Levothyroxine Sodium | 64 | $751 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $702 |
| Calcitonin-SalmonCalcitonin,salmon,synthetic | 14 | $695 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $687 |
| NitrofurantoinNitrofurantoin Macrocrystal | 12 | $334 |
| Gabapentin | 30 | $322 |
| Tizanidine Hcl | 14 | $307 |
| Atorvastatin Calcium | 47 | $263 |
| Doxycycline Hyclate | 31 | $244 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $237 | $49,80149 claims |
| Novo NordiskOzempic, Rybelsus | $981 | $32,17626 claims |
| GSKTrelegy Ellipta, Shingrix | $217 | $32,07540 claims |
| Boehringer IngelheimJardiance | $206 | $27,63427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.
Other family in Hickory
- Kelly HolmesHickory$55K
- Tanya DyerHickory$21K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.